| G9a, a multipotent regulator of gene expression SR Shankar, AG Bahirvani, VK Rao, N Bharathy, JR Ow, R Taneja Epigenetics 8 (1), 16-22, 2013 | 197 | 2013 |
| Oxidative stress-mediated skeletal muscle degeneration: molecules, mechanisms, and therapies MH Choi, JR Ow, ND Yang, R Taneja Oxidative Medicine and Cellular Longevity 2016, 2016 | 87 | 2016 |
| G9a promotes proliferation and inhibits cell cycle exit during myogenic differentiation VK Rao, JR Ow, SR Shankar, N Bharathy, J Manikandan, Y Wang, ... Nucleic acids research 44 (17), 8129-8143, 2016 | 51 | 2016 |
| Patz1 regulates embryonic stem cell identity JR Ow, H Ma, A Jean, Z Goh, YH Lee, YM Chong, R Soong, XY Fu, ... Stem cells and development 23 (10), 1062-1073, 2014 | 47 | 2014 |
| Stra13 and Sharp-1, the non-grouchy regulators of development and disease JR Ow, YH Tan, Y Jin, AG Bahirvani, R Taneja Current topics in developmental biology 110, 317-338, 2014 | 41 | 2014 |
| Loss of hepatocyte cell division leads to liver inflammation and fibrosis MR Dewhurst, JR Ow, G Zafer, NKM van Hul, H Wollmann, X Bisteau, ... PLoS genetics 16 (11), e1009084, 2020 | 34 | 2020 |
| P/CAF mediates PAX3–FOXO1‐dependent oncogenesis in alveolar rhabdomyosarcoma N Bharathy, S Suriyamurthy, VK Rao, JR Ow, HJ Lim, P Chakraborty, ... The Journal of pathology 240 (3), 269-281, 2016 | 23 | 2016 |
| The dosage of Patz1 modulates reprogramming process H Ma, JR Ow, BCP Tan, Z Goh, B Feng, YH Loh, M Fedele, H Li, Q Wu Scientific reports 4 (1), 7519, 2014 | 21 | 2014 |
| G9a inhibits MEF2C activity to control sarcomere assembly JR Ow, M Palanichamy Kala, VK Rao, MH Choi, N Bharathy, R Taneja Scientific Reports 6 (1), 34163, 2016 | 16 | 2016 |
| MetaboKit: A comprehensive data extraction tool for untargeted metabolomics P Narayanaswamy, G Teo, JR Ow, A Lau, P Kaldis, S Tate, H Choi Molecular omics 16 (5), 436-447, 2020 | 14 | 2020 |
| Remodeling of whole-body lipid metabolism and a diabetic-like phenotype caused by loss of CDK1 and hepatocyte division JR Ow, MJ Caldez, G Zafer, JC Foo, HY Li, S Ghosh, H Wollmann, ... Elife 9, e63835, 2020 | 13 | 2020 |
| Liver-derived metabolites as signaling molecules in fatty liver disease U Keles, JR Ow, KB Kuentzel, LN Zhao, P Kaldis Cellular and Molecular Life Sciences 80 (1), 4, 2023 | 9 | 2023 |
| Zfp553 is essential for maintenance and acquisition of pluripotency S Yu, H Ma, JR Ow, Z Goh, R Chiang, H Yang, YH Loh, Q Wu Stem cells and development 25 (1), 55-67, 2016 | 8 | 2016 |
| GLP inhibits heterochromatin clustering and myogenic differentiation by repressing MeCP2 MH Choi, M Palanichamy Kala, JR Ow, VK Rao, S Suriyamurthy, ... Journal of molecular cell biology 10 (2), 161-174, 2018 | 6 | 2018 |
| G9a/GLP inhibition during ex vivo lymphocyte expansion increases in vivo cytotoxicity of engineered T cells against hepatocellular carcinoma MSY Lam, JA Reales-Calderon, JR Ow, JJY Aw, D Tan, R Vijayakumar, ... Nature Communications 14 (1), 563, 2023 | 5 | 2023 |
| In vitro 3D liver tumor microenvironment models for immune cell therapy optimization M Lam, JA Reales-Calderon, JR Ow, G Adriani, A Pavesi APL bioengineering 5 (4), 2021 | 3 | 2021 |
| Microphysiological vascularized solid liver tumor model for drug and cell therapy J Vasudevan, R Vijayakumar, JA Reales-Calderon, MS Lam, JR Ow, J Aw, ... Cancer Research 83 (7_Supplement), 4612-4612, 2023 | 1 | 2023 |
| With or without them: essential roles of cofactors in ES cells H Ma, JR Ow, X Chen, Q Wu J Stem Cell Res Ther, 1-9, 2012 | 1 | 2012 |
| Splice-switching oligonucleotides as therapeutics for citrin deficiency patients with a novel deep intronic variant K Oishi, JR Ow, E Imagawa, WY Cher, V Ramadass, T Tabaglio, ... Molecular Genetics and Metabolism 141 (4), 108318, 2024 | | 2024 |
| To B (enign) or Not to B: functionalisation of variant in a mild form of argininosuccinate lyase deficiency identified through newborn screening TYJ Heng, JR Ow, AL Koh, JSC Lim, CBK Ong, JCY Goh, JY Lim, ... Clinical Dysmorphology 33 (1), 43-49, 2024 | | 2024 |
